Neutralizing epitope-based growth enhancing vaccine

Details for Australian Patent Application No. 2004312411 (hide)

Owner Schering-Plough Ltd.

Inventors Cochran, Mark D.; Junker, David E.

Agent Griffith Hack

Pub. Number AU-B-2004312411

PCT Pub. Number WO2005/066204

Priority 60/533,719 31.12.03 US

Filing date 21 December 2004

Wipo publication date 21 July 2005

Acceptance publication date 3 November 2011

International Classifications

C07K 14/475 (2006.01) Peptides having more than 20 amino acids

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

C07K 14/495 (2006.01) Peptides having more than 20 amino acids

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

6 July 2006 PCT application entered the National Phase

  PCT publication WO2005/066204 Priority application(s): WO2005/066204

3 November 2011 Application Accepted

  Published as AU-B-2004312411

24 November 2011 Corrigenda

  Applications Accepted - Name Index Under the name Schering-Plough Ltd., Application No. 2004312411, under INID (71) correct the applicant name to Schering-Plough Pty. Limited

1 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004312413-Pyrrolotriazine compounds as kinase inhibitors

2004312407